Fig. 1From: Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patientsThe abundance of CD8+ TILs in the rectal tumour microenvironment before neoadjuvant chemoradiotherapy has been correlated to patient prognosis. Higher expression of CD8+ T cells pre-treatment leads to a more favorable patient prognosisBack to article page